Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000409439 | SCV000486304 | likely pathogenic | Charlevoix-Saguenay spastic ataxia | 2016-05-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003750785 | SCV004387270 | pathogenic | Spastic paraplegia | 2023-10-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro10Argfs*2) in the SACS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SACS are known to be pathogenic (PMID: 18465152, 20876471). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SACS-related conditions. ClinVar contains an entry for this variant (Variation ID: 370878). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000409439 | SCV005055545 | likely pathogenic | Charlevoix-Saguenay spastic ataxia | 2024-01-08 | criteria provided, single submitter | clinical testing |